Home Myocardial amyloidosis following multiple myeloma in a 38-year-old female patient: A case report
Article Open Access

Myocardial amyloidosis following multiple myeloma in a 38-year-old female patient: A case report

  • Qisi Zhang , Yingli Qiao , Dongmei Yan , Yuhui Deng EMAIL logo , Mengyang Zhang and Poshi Xu EMAIL logo
Published/Copyright: May 16, 2020

Abstract

Multiple myeloma (MM) is an immunoglobulin-producing tumor of plasma cells, which occurs commonly in the elderly. The incidence of myocardial amyloidosis with MM is extremely low and early clinical manifestations are nonspecific. The diversity of clinical manifestations and first episode symptoms often cause misdiagnosis in young patients with myocardial amyloidosis following MM. In this study, we analyzed the clinical data of a young woman with MM and impaired cardiac function combined with echocardiography, electrocardiography (ECG), laboratory data, cell Congo Red staining, and other manifestations to diagnose amyloidosis. Considering the rapid progression, short survival, and poor prognosis in most patients, a clear, definitive, and timely diagnosis is essential for the treatment of patients with MM complicated with myocardial amyloidosis.

1 Introduction

Multiple myeloma (MM) is an immunoglobulin-producing tumor of plasma cells, which is commonly seen in the elderly [1,2]. The diversity of clinical manifestations and first episode symptoms often cause misdiagnosis in young patients with MM. The probability of amyloidosis in patients with MM is about 5–10% [3]. There are often no characteristic clinical symptoms initially. Considering the rapid progression, short survival, and poor prognosis in most patients, a clear and timely diagnosis is essential for the treatment of patients with MM complicated with myocardial amyloidosis. In this paper, we report the case of a 38-year-old woman with MM and heart failure. The granular sparkling pattern of myocardium was found on echocardiography that prompted further evaluation.

2 Case

A 38-year-old woman was admitted to our hospital due to fatigue, bloating, edema of both lower extremities, and increased wheezing after activity in November 2018. Initial examination revealed creatinine elevation, left heart hypertrophy, and hypertension. She reported acute episodes of bloating, edema in the lower extremities, and wheezing during the previous 1 month; she denied history of any cardiovascular disease or family history of cardiovascular disease. Physical examination at admission showed pale skin and mucous membranes, enlarged liver (4–5 cm below the costal margin), edema of the lower limbs and varicose veins, and hypertension (blood pressure: 170/105 mm Hg). Laboratory results showed decreased total serum protein (52.6 g/L), serum albumin (33.9 g/L), and immunoglobulins (IgG, 2.05 g/L; IgA, 0.10 g/L; IgM, 0.01 g/L) as well as elevated 24-hour urinary total protein (2.93 g/24 h) (Table 1). Immuno fixation electrophoresis (IFE) revealed a positive result for κ-light chains (Figure 1). Color Doppler showed enhanced echogenicity of the kidneys. Computerized tomography showed bilateral pleural effusion; whole-body bone imaging or scan showed a mild increase in ingested radioactivity in the shoulder joint, sternum, and bilateral hip joints. For further evaluation, a bone marrow aspirate was performed. The bone marrow aspirate showed bone marrow changes typically seen in MM (Figure 2) and in combination with flow cytometry, plasma cells accounted for 58% of the total cell count. The results of fluorescence in situ hybridization showed that the 13q14 locus signal was deleted and the 14q32 locus gene rearrangement was positive. According to the National Comprehensive Cancer Network (NCCN) guidelines insights: MM (version 3.2016) [4], the condition of this female patient was diagnosed as MM.

Table 1

Laboratory results during hospitalization

Laboratory results (unit)Jan 03, 2019Mar 28, 2019Apr 12, 2019Jan 02, 2020
TP (g/L)51.460.061.858.0
Serum albumin (g/L)36.744.543.837.4
BUN (mmol/L)21.422.011.114.2
Creatinine (µmmol/L)239221205418
eGFR (mL/min)35.6734.9430.922.15
NT-proBNP (pg/mL)17,87159,94086,2082,81,168

TP = total serum protein; BUN = blood urea nitrogen; eGFR = estimation of glomerular filtration rate; NT-proBNP = N-terminal pro-B-type natriuretic peptide.

Figure 1 Serum immobilized electrophoresis (IFE) revealed positive result for κ-light chains.
Figure 1

Serum immobilized electrophoresis (IFE) revealed positive result for κ-light chains.

Figure 2 The bone marrow image showed an MM bone marrow change (Wright stain).
Figure 2

The bone marrow image showed an MM bone marrow change (Wright stain).

Table 2

Echocardiographic analysis results

Variables (unit)Jan 03, 2019Mar 28, 2019Jan 02, 2020
LVEDV (mL)1249393
LVESV (mL)515152
LVEF (%)58.146.243.3
SV (mL)72.143.040.4
LVIDD (mm)514245
LVIDS (mm)353435
FS (%)30.923.021.6
Left atrial anteroposterior diameter (mm)414245
Left ventricle anteroposterior diameter (mm)514548
Right atrium transverse diameter (mm)334748
Right atrium longitudinal diameter (mm)535761
Right ventricular anteroposterior diameter (mm)252322
IVS (mm)121213
LVPW (mm)121213

LVEDV = left ventricular end-diastolic volume; LVESV = left ventricular end-systolic volume; LVEF = left ventricular ejection fraction; SV = Stroke volume; LVIDD = left ventricular end-diastolic diameter; LVIDS = left ventricular end-systolic diameter; FS = fractional shortening; IVS = interventricular septal thickness; LVPW = left ventricular posterior wall.

Figure 3 Echocardiography showing increased ventricular mass and granular sparkling pattern of myocardium (black arrows).
Figure 3

Echocardiography showing increased ventricular mass and granular sparkling pattern of myocardium (black arrows).

Figure 4 ECG showed ST-T abnormality after 3 months of admission.
Figure 4

ECG showed ST-T abnormality after 3 months of admission.

Figure 5 Oral mucosal exfoliated cells showing multiple deposits of amyloid, positive for Red Congo stain (left) and with yellow birefringence under polarized light (right).
Figure 5

Oral mucosal exfoliated cells showing multiple deposits of amyloid, positive for Red Congo stain (left) and with yellow birefringence under polarized light (right).

During the hospital admission, the patient suffered from the rapid progress of wheezing, breathlessness in the sitting position, and evident chest tightness. Laboratory results revealed the following: N-terminal pro-B-type natriuretic peptide (NT-proBNP), 12,800 pg/mL; cardiac troponin T, 63.67 pg/mL; creatine kinase-MB, 9.02 ng/mL; and myoglobin, 97.68 ng/mL (Table 1). The initial echocardiography showed an enlarged heart, symmetrical thickening of the left ventricular wall, slightly enhanced echo, slightly reduced left ventricular systolic function (ejection fraction, 58%; fractional shortening, 30%), and minimal pericardial effusion. Mitral insufficiency, tricuspid insufficiency, and mild regurgitation were explored in the systolic phase. During hospitalization, echocardiography showed a further reduction in left ventricular systolic function and left ventricular diastolic function (Table 2) and granular sparkling pattern of the myocardium (Figure 3). One month after admission, electrocardiography (ECG) showed ST-T abnormalities as opposed to the initial normal ECG (Figure 4). In the next 3 months, the ECG still showed ST-T abnormalities and no low voltage performance. Cardiac magnetic resonance imaging (MRI) showed no subendocardial tissue enhancement by gadolinium. The combination of the New York Heart Association class III heart failure and history of MM was highly suggestive of a diagnosis of myocardial amyloidosis. Oral mucosal exfoliated cells showed positive staining for Congo Red stain (Figure 5). Furthermore, indentations on the tongue could be seen as the patient had macroglossia.

  1. Informed consent: Informed consent has been obtained from patient included in this study.

3 Treatments

The patient was started on specific treatment with 40 mg of dexamethasone alone for 4 days. Immunosuppressants were replaced with a combination of intravenous (iv) bortezomib, 1.3 mg/m2 on days 1, 4, 8, and 11; thalidomide, 100 mg continuously; and dexamethasone 40 mg on days 1, 2, 8, 9, 15, 16, 22, and 23 for four 28-day cycles [5]. Diuretics are the mainstay of supportive care in cardiac amyloidosis. Furosemide (20 mg orally, once a day) and spironolactone (20 mg orally, once a day) in combination with hydrochlorothiazide (25 mg orally, three times a day) were used to alleviate cardiac preload and edema [6]. Torasemide (20 mg iv, once a day) was given instead of furosemide when the patient developed oliguria.

After four courses of treatment, plasma cells accounted for 71% of cell count on flow cytometry with the patient showing no remission. Progression of heart failure and renal failure was evident during the follow-up visit.

4 Discussion

The clinical manifestations and the initial symptoms of MM are diverse. MM usually occurs in people aged 65–74 years. The median age of onset is 69 years, and the ratio of male to female patients is about 1.58:1 [7]. As per statistics, only 3.2% of the patients are younger than 44 years, and patients aged 35 to 44 years account for 2.5% of the total cases [7]. Our patient was a 38-year-old young woman with renal and cardiac dysfunction as the initial manifestations. Abnormal blood cells and osteolytic symptoms were not evident. According to the diagnostic criteria of NCCN guidelines insights: MM [4], the patient was diagnosed as MM. However, this diagnosis can be easily missed because of the typical characteristics of susceptible populations. Therefore, young patients with MM should be carefully and comprehensively evaluated to arrive at the correct diagnosis.

The abnormal folding of light chains, rich in β leaves, due to changes in the secondary or tertiary structure of monoclonal immunoglobulins can form amyloid fibrils, which can lead to amyloidosis after extracellular deposition [8]. The probability of amyloidosis in patients with MM is about 10–15%. As with MM, amyloidosis was universally present in the elderly (median age, 64 years), and 99% were 40 years or older except one in a study comprising 474 patients [9]. Reports in recent years show the same results: 37 (60.7%) male, age 60 ± 11 years (n = 61) [10], 94 (74.0%) male, mean age, 61 years (n = 127) [11]. Amyloid deposits can occur in various organs, including heart, kidney, liver, and peripheral nervous system. Kidney involvement is the most common among the abovementioned organs and tissues with clinical cardiac involvement being the second most common presenting feature. According to a 2017 study, the mean age of patients with cardiac amyloidosis was 60 years (interquartile range, 54–68 years); 28 (59.6%) were men [10], which is analogous to the previous report (68 ± 10 years) [12]. Cardiac amyloidosis often has no characteristic clinical symptoms initially, but eventually heart failure ensues. For the Chinese population, aged 18–44 years, the reported average age of patients with heart failure and male and female patients are 36.82 ± 7.17 years, 37.44 ± 5.65 years, and 34.9 ± 7.17 years, respectively. The most common causes are dilated cardiomyopathy (31.0%), ischemic heart disease (29.6%), hypertensive heart disease (14.1%), peripartum cardiomyopathy (5.2%), and congenital heart disease (4.7%). Among male patients, ischemic heart disease and dilated cardiomyopathy are the most common causes, which account for 33.8% and 32.5% cases, respectively. Unlike male patients, dilated cardiomyopathy (26.4%) and peripartum cardiomyopathy (20.8%) are the most common causes among female patients [13]. Thus, a young female patient with myocardial amyloidosis following MM is rare and should be diagnosed cautiously.

ECG, echocardiography, and cardiac MRI are also important proofs for the diagnosis of myocardial amyloidosis. Studies have shown that the most characteristic ECG manifestation in patients with myocardial amyloidosis is the low-voltage pattern [14]. Typical echocardiography is characterized by thickening of the left ventricular wall with a granular sparkling appearance in the absence of hypertension and a limited or diffuse tissue enhancement of the heart by gadolinium on MRI. The combination of the characteristic findings of these three tests should be considered to make a diagnosis of cardiac amyloidosis. A study describing the clinical characteristics of eight patients with cardiac amyloidosis caused by MM reported that seven cases out of eight (87.5%) showed low limb lead voltage, six (75.0%) cases had poor precordial R-wave progression or pseudo-necrotic Q wave, and three (37.5%) cases presented with ST-T abnormalities [15]. This report showed different ECG characteristics in patients with myocardial amyloidosis. Low-voltage QRS complex also reportedly occurs in approximately 45–60% of the patients with AL amyloidosis; however, the absence of low-voltage QRS complex does not exclude the diagnosis of AL amyloidosis [11,16]. Echocardiography of this patient showed an enlarged heart, symmetrical thickening of the left ventricular wall, and left ventricular systolic dysfunction. There was no typical granular echo enhancement in the early stages of admission, which was seen only 4 months later. MRI did not show obvious enhancement by gadolinium. The initial ECG after admission was normal, but ST-T abnormalities appeared after 1 month, accompanied by increasing levels of NT-proBNP, combined with the rapid development of heart failure; however, there was no family history of heart disease; common heart diseases causing left heart failure were ruled out and the presence of cardiomyopathy was suggested. The patient had no symptoms of infection or bleeding, and there were no typical changes on MRI and echocardiography. This may be related to better cardiovascular functions, and the absence of complications, such as diabetes.

The pathological biopsy is the only means to confirm myocardial amyloidosis. Myocardial amyloidosis can be confirmed by combining positive results on ECG, echocardiography, and MRI with biopsy tissue Congo Red staining, but negative results of Congo Red staining do not rule out myocardial amyloidosis. However, because of poor cardiac function in patients with myocardial amyloidosis, blind examinations such as that of kidney tissue, abdominal adipose tissue, and intestinal tissue are often used as substitutes for myocardial biopsy. The positivity rates of different tissue specimens stained with Congo Red were reported as follows: abdominal fat, 50–80%; bone marrow, 56%; rectum, 75%; kidney, 94%; carpal ligament, 82%; liver, 97%; small intestine, 83%; skin, 90%; sural nerve, 86%; and heart, 100% [9,17]. The positivity rate of oral mucosa Congo Red staining in patients with primary amyloidosis has not been reported so far. However, the buccal mucosa was the most common site of amyloid deposition in the oral cavity, followed by the tongue, palate, gingiva, and floor of the mouth [18]. Systemic involvement is common: 90% of the patients with systemic amyloidosis will develop deposits in the head, neck, or respiratory tract [19]. About 25% of the patients with amyloidosis will develop macroglossia, the tongue becoming enlarged and firm, often with peripheral indentations from the teeth [20,21]. Recently, a study pointed out that among the 13 confirmed patients, 7 (54%) patients had clinical manifestations of oral amyloidosis (mainly macroglossia, indentations on the lateral border of the tongue, hematoma/ecchymosis), and in 5 of these 7 patients, the presence of amyloid deposition was confirmed by Congo Red staining of the diseased oral tissue [22]. The patient had indentations on the tongue and suffered from macroglossia. Because of the patient’s wishes, an invasive biopsy could not be taken. Therefore, we used a swab to scrape the oral mucosa for Congo Red staining. The Congo Red staining showed a yellow birefringence with apple-green birefringence under polarized light. This phenomenon is related to microscopy optics. If the optics are not perfect, which is almost inevitable on most microscopes, a mixture of colors is seen, typically blue-green and yellow-green, which can be called green and yellow, or even definite blue and yellow, without any green at all [23]. Combining the clinical and other features with the aforementioned literature reports, we suspected the presence of amyloidosis in the mouth and tongue. Considering that the patient had shown signs of multiple organ involvement (renal failure, heart failure, and macroglossia), the positive results of oral mucosa Congo Red stain confirmed systemic amyloidosis indirectly. Myocardial amyloidosis is more commonly seen than oral amyloidosis for the reason that the heart is the second most common site in amyloidosis. Combined with the typical echocardiography changes in myocardial amyloidosis, the positive result of oral mucosa Congo Red stain can indicate a diagnosis of highly suspicious for myocardial amyloidosis.

5 Conclusions

Myocardial amyloidosis should be considered in patients with MM presenting without subendocardial tissue enhancement by gadolinium on MRI and low voltage on ECG when Congo Red staining of biopsy tissue is positive; echocardiography shows the granular sparkling pattern of the myocardium and ECG shows ST-T abnormalities.


These authors contributed equally to this work.


  1. Funding sources: This research was supported by a grant from the Henan Medical Science and Technology Research Project (2018020472) and the Henan Science and Technology Research Project (172102310114).

  2. Conflicts of interest: The authors have no conflicts of interest.

References

[1] Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364(11):1046–60. 10.1056/NEJMra1011442.Search in Google Scholar

[2] Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC. Multiple myeloma. Lancet. 2009;374(9686):324–39. 10.1016/S0140-6736(09)60221-X.Search in Google Scholar

[3] Falk RH, Alexander KM, Liao R, Dorbala S, (Light-Chain) AL. Cardiac amyloidosis: a review of diagnosis and therapy. J Am Coll Cardiol. 2016;68(12):1323–41. 10.1016/j.jacc.2016.06.053.Search in Google Scholar PubMed

[4] Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WR, et al. NCCN guidelines insights: melanoma, version 3.2016. J Natl Compr Canc Netw. 2016;14(8):945–58. 10.6004/jnccn.2016.0101.Search in Google Scholar PubMed

[5] Dispenzieri A, Buadi F, Kumar SK, Reeder CB, Sher T, Lacy MQ, et al. Treatment of immunoglobulin light chain amyloidosis: mayo stratification of myeloma and risk-adapted therapy (mSMART) consensus statement. Mayo Clin Proc. 2015;90(8):1054–81. 10.1016/j.mayocp.2015.06.009.Search in Google Scholar PubMed

[6] Alexander KM, Evangelisti A, Witteles RM. Diagnosis and treatment of cardiac amyloidosis related to plasma cell dyscrasias. Cardiol Clin. 2019;37(4):487–95. 10.1016/j.ccl.2019.07.013.Search in Google Scholar PubMed

[7] Surveillance, Epidemiology, and End Results Program Turning Cancer Data Into Discovery, 2012–2016 statistics at a glance, http://seer.cancer.gov/statfacts/html/mulmy.html; 2020 [cited 20.01.22]Search in Google Scholar

[8] Desport E, Bridoux F, Sirac C, Delbes S, Bender S, Fernandez B, et al. Al amyloidosis. Orphanet J Rare Dis. 2012;7:54. 10.1186/1750-1172-7-54.Search in Google Scholar PubMed PubMed Central

[9] Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32(1):45–59.Search in Google Scholar

[10] Wan K, Sun J, Han Y, Luo Y, Liu H, Yang D, et al. Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis. Heart Vessels. 2018;33(2):170–9. 10.1007/s00380-017-1043-y.Search in Google Scholar PubMed PubMed Central

[11] Murtagh B, Hammill SC, Gertz MA, Kyle RA, Tajik AJ, Grogan M. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol. 2005;95(4):535–7. 10.1016/j.amjcard.2004.10.028.Search in Google Scholar PubMed

[12] Phelan D, Collier P, Thavendiranathan P, Popovic ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98(19):1442–8. 10.1136/heartjnl-2012-302353.Search in Google Scholar PubMed

[13] Chaohong J. A retrospective analysis of clinical data of 213 young adult patients with heart failure. Master's thesis, Jilin University. 2019. p. 6 (in Chinese with English abstract).Search in Google Scholar

[14] Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med. 2006;166(17):1805–13. 10.1001/archinte.166.17.1805.Search in Google Scholar

[15] Hui Q, Aidong S, Zhijun S, Hongwei L. Clinical characteristics of 8 patients with cardiac amyloidosis caused by multiple myeloma. Chin J Cardiovasc Med. 2018;23(3):219–33. 10.3969/j.issn.1007-5410.2018.03.009.Search in Google Scholar

[16] Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation. 2009;120(13):1203–12. 10.1161/CIRCULATIONAHA.108.843334.Search in Google Scholar

[17] Gillmore JD, Wechalekar A, Bird J, Cavenagh J, Hawkins S, Kazmi M, et al. Guidelines on the diagnosis and investigation of AL amyloidosis. Br J Haematol. 2015;168(2):207–18. 10.1111/bjh.13156.Search in Google Scholar

[18] Stoopler ET, Sollecito TP, Chen SY. Amyloid deposition in the oral cavity: a retrospective study and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95(6):674–80. 10.1067/moe.2003.136.Search in Google Scholar

[19] Lebowitz RA, Morris L. Plasma cell dyscrasias and amyloidosis. Otolaryngol Clin North Am. 2003;36(4):747–64. 10.1016/s0030-6665(03)00026-4.Search in Google Scholar

[20] Skinner M, Anderson J, Simms R, Falk R, Wang M, Libbey C, et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med. 1996;100(3):290–8. 10.1016/s0002-9343(97)89487-9.Search in Google Scholar

[21] Favia G, Lacaita MG, Laforgia PD. Oromaxillary amyloidosis. Classification, etiopathogenesis and clinical immunopathological and histochemical study. Minerva Stomatol. 1984;33(2):223–30.Search in Google Scholar

[22] Leiba M, Jarjoura S, Abboud W, Nagler A, Yahalom R, Duek A, et al. Role of oral examination in newly diagnosed multiple myeloma patients: A safe and simple way to detect light chain amyloidosis. Oral Dis. 2018;24(7):1343–8. 10.1111/odi.12901.Search in Google Scholar PubMed

[23] Howie AJ. Origins of a pervasive, erroneous idea: the “green birefringence” of Congo Red-stained amyloid. Int J Exp Pathol. 2019;100(4):208–21. 10.1111/iep.12330.Search in Google Scholar PubMed PubMed Central

Received: 2019-12-01
Revised: 2020-03-12
Accepted: 2020-03-19
Published Online: 2020-05-16

© 2020 Qisi Zhang et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Article
  2. MicroRNA-451b participates in coronary heart disease by targeting VEGFA
  3. Case Report
  4. A combination therapy for Kawasaki disease with severe complications: a case report
  5. Vitamin E for prevention of biofilm-caused Healthcare-associated infections
  6. Research Article
  7. Differential diagnosis: retroperitoneal fibrosis and oncological diseases
  8. Optimization of the Convolutional Neural Networks for Automatic Detection of Skin Cancer
  9. NEAT1 promotes LPS-induced inflammatory injury in macrophages by regulating miR-17-5p/TLR4
  10. Plasma matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 as prognostic biomarkers in critically ill patients
  11. Effects of extracorporeal magnetic stimulation in fecal incontinence
  12. Case Report
  13. Mixed germ cell tumor of the endometrium: a case report and literature review
  14. Bowel perforation after ventriculoperitoneal-shunt placement: case report and review of the literature
  15. Research Article
  16. Prognostic value of lncRNA HOTAIR in colorectal cancer : a meta-analysis
  17. Case Report
  18. Treatment of insulinomas by laparoscopic radiofrequency ablation: case reports and literature review
  19. Research Article
  20. The characteristics and nomogram for primary lung papillary adenocarcinoma
  21. Undiagnosed pheochromocytoma presenting as a pancreatic tumor: A case report
  22. Bioinformatics Analysis of the Expression of ATP binding cassette subfamily C member 3 (ABCC3) in Human Glioma
  23. Diagnostic value of recombinant heparin-binding hemagglutinin adhesin protein in spinal tuberculosis
  24. Primary cutaneous DLBCL non-GCB type: challenges of a rare case
  25. LINC00152 knock-down suppresses esophageal cancer by EGFR signaling pathway
  26. Case Report
  27. Life-threatening anaemia in patient with hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)
  28. Research Article
  29. QTc interval predicts disturbed circadian blood pressure variation
  30. Shoulder ultrasound in the diagnosis of the suprascapular neuropathy in athletes
  31. The number of negative lymph nodes is positively associated with survival in esophageal squamous cell carcinoma patients in China
  32. Differentiation of pontine infarction by size
  33. RAF1 expression is correlated with HAF, a parameter of liver computed tomographic perfusion, and may predict the early therapeutic response to sorafenib in advanced hepatocellular carcinoma patients
  34. LncRNA ZEB1-AS1 regulates colorectal cancer cells by miR-205/YAP1 axis
  35. Tissue coagulation in laser hemorrhoidoplasty – an experimental study
  36. Classification of pathological types of lung cancer from CT images by deep residual neural networks with transfer learning strategy
  37. Enhanced Recovery after Surgery for Lung Cancer Patients
  38. Case Report
  39. Streptococcus pneumoniae-associated thrombotic microangiopathy in an immunosuppressed adult
  40. Research Article
  41. The characterization of Enterococcus genus: resistance mechanisms and inflammatory bowel disease
  42. Case Report
  43. Inflammatory fibroid polyp: an unusual cause of abdominal pain in the upper gastrointestinal tract A case report
  44. Research Article
  45. microRNA-204-5p participates in atherosclerosis via targeting MMP-9
  46. LncRNA LINC00152 promotes laryngeal cancer progression by sponging miR-613
  47. Can keratin scaffolds be used for creating three-dimensional cell cultures?
  48. miRNA-186 improves sepsis induced renal injury via PTEN/PI3K/AKT/P53 pathway
  49. Case Report
  50. Delayed bowel perforation after routine distal loopogram prior to ileostomy closure
  51. Research Article
  52. Diagnostic accuracy of MALDI-TOF mass spectrometry for the direct identification of clinical pathogens from urine
  53. The R219K polymorphism of the ATP binding cassette subfamily A member 1 gene and susceptibility to ischemic stroke in Chinese population
  54. miR-92 regulates the proliferation, migration, invasion and apoptosis of glioma cells by targeting neogenin
  55. Clinicopathological features of programmed cell death-ligand 1 expression in patients with oral squamous cell carcinoma
  56. NF2 inhibits proliferation and cancer stemness in breast cancer
  57. Body composition indices and cardiovascular risk in type 2 diabetes. CV biomarkers are not related to body composition
  58. S100A6 promotes proliferation and migration of HepG2 cells via increased ubiquitin-dependent degradation of p53
  59. Review Article
  60. Focus on localized laryngeal amyloidosis: management of five cases
  61. Research Article
  62. NEAT1 aggravates sepsis-induced acute kidney injury by sponging miR-22-3p
  63. Pericentric inversion in chromosome 1 and male infertility
  64. Increased atherogenic index in the general hearing loss population
  65. Prognostic role of SIRT6 in gastrointestinal cancers: a meta-analysis
  66. The complexity of molecular processes in osteoarthritis of the knee joint
  67. Interleukin-6 gene −572 G > C polymorphism and myocardial infarction risk
  68. Case Report
  69. Severe anaphylactic reaction to cisatracurium during anesthesia with cross-reactivity to atracurium
  70. Research Article
  71. Rehabilitation training improves nerve injuries by affecting Notch1 and SYN
  72. Case Report
  73. Myocardial amyloidosis following multiple myeloma in a 38-year-old female patient: A case report
  74. Research Article
  75. Identification of the hub genes RUNX2 and FN1 in gastric cancer
  76. miR-101-3p sensitizes non-small cell lung cancer cells to irradiation
  77. Distinct functions and prognostic values of RORs in gastric cancer
  78. Clinical impact of post-mortem genetic testing in cardiac death and cardiomyopathy
  79. Efficacy of pembrolizumab for advanced/metastatic melanoma: a meta-analysis
  80. Review Article
  81. The role of osteoprotegerin in the development, progression and management of abdominal aortic aneurysms
  82. Research Article
  83. Identification of key microRNAs of plasma extracellular vesicles and their diagnostic and prognostic significance in melanoma
  84. miR-30a-3p participates in the development of asthma by targeting CCR3
  85. microRNA-491-5p protects against atherosclerosis by targeting matrix metallopeptidase-9
  86. Bladder-embedded ectopic intrauterine device with calculus
  87. Case Report
  88. Mycobacterial identification on homogenised biopsy facilitates the early diagnosis and treatment of laryngeal tuberculosis
  89. Research Article
  90. The will of young minors in the terminal stage of sickness: A case report
  91. Extended perfusion protocol for MS lesion quantification
  92. Identification of four genes associated with cutaneous metastatic melanoma
  93. Case Report
  94. Thalidomide-induced serious RR interval prolongation (longest interval >5.0 s) in multiple myeloma patient with rectal cancer: A case report
  95. Research Article
  96. Voluntary exercise and cardiac remodeling in a myocardial infarction model
  97. Electromyography as an intraoperative test to assess the quality of nerve anastomosis – experimental study on rats
  98. Case Report
  99. CT findings of severe novel coronavirus disease (COVID-19): A case report of Heilongjiang Province, China
  100. Commentary
  101. Directed differentiation into insulin-producing cells using microRNA manipulation
  102. Research Article
  103. Culture-negative infective endocarditis (CNIE): impact on postoperative mortality
  104. Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome
  105. Plasma microRNAs in human left ventricular reverse remodelling
  106. Bevacizumab for non-small cell lung cancer patients with brain metastasis: A meta-analysis
  107. Risk factors for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage
  108. Problems and solutions of personal protective equipment doffing in COVID-19
  109. Evaluation of COVID-19 based on ACE2 expression in normal and cancer patients
  110. Review Article
  111. Gastroenterological complications in kidney transplant patients
  112. Research Article
  113. CXCL13 concentration in latent syphilis patients with treatment failure
  114. A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction
  115. Case Report
  116. Clinicopathological analysis of composite lymphoma: A two-case report and literature review
  117. Trastuzumab-induced thrombocytopenia after eight cycles of trastuzumab treatment
  118. Research Article
  119. Inhibition of vitamin D analog eldecalcitol on hepatoma in vitro and in vivo
  120. CCTs as new biomarkers for the prognosis of head and neck squamous cancer
  121. Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet
  122. 72 hour Holter monitoring, 7 day Holter monitoring, and 30 day intermittent patient-activated heart rhythm recording in detecting arrhythmias in cryptogenic stroke patients free from arrhythmia in a screening 24 h Holter
  123. FOXK2 downregulation suppresses EMT in hepatocellular carcinoma
  124. Case Report
  125. Total parenteral nutrition-induced Wernicke’s encephalopathy after oncologic gastrointestinal surgery
  126. Research Article
  127. Clinical prediction for outcomes of patients with acute-on-chronic liver failure associated with HBV infection: A new model establishment
  128. Case Report
  129. Combination of chest CT and clinical features for diagnosis of 2019 novel coronavirus pneumonia
  130. Research Article
  131. Clinical significance and potential mechanisms of miR-223-3p and miR-204-5p in squamous cell carcinoma of head and neck: a study based on TCGA and GEO
  132. Review Article
  133. Hemoperitoneum caused by spontaneous rupture of hepatocellular carcinoma in noncirrhotic liver. A case report and systematic review
  134. Research Article
  135. Voltage-dependent anion channels mediated apoptosis in refractory epilepsy
  136. Prognostic factors in stage I gastric cancer: A retrospective analysis
  137. Circulating irisin is linked to bone mineral density in geriatric Chinese men
  138. Case Report
  139. A family study of congenital dysfibrinogenemia caused by a novel mutation in the FGA gene: A case report
  140. Research Article
  141. CBCT for estimation of the cemento-enamel junction and crestal bone of anterior teeth
  142. Case Report
  143. Successful de-escalation antibiotic therapy using cephamycins for sepsis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia: A sequential 25-case series
  144. Research Article
  145. Influence factors of extra-articular manifestations in rheumatoid arthritis
  146. Assessment of knowledge of use of electronic cigarette and its harmful effects among young adults
  147. Predictive factors of progression to severe COVID-19
  148. Procedural sedation and analgesia for percutaneous trans-hepatic biliary drainage: Randomized clinical trial for comparison of two different concepts
  149. Acute chemoradiotherapy toxicity in cervical cancer patients
  150. IGF-1 regulates the growth of fibroblasts and extracellular matrix deposition in pelvic organ prolapse
  151. NANOG regulates the proliferation of PCSCs via the TGF-β1/SMAD pathway
  152. An immune-relevant signature of nine genes as a prognostic biomarker in patients with gastric carcinoma
  153. Computer-aided diagnosis of skin cancer based on soft computing techniques
  154. MiR-1225-5p acts as tumor suppressor in glioblastoma via targeting FNDC3B
  155. miR-300/FA2H affects gastric cancer cell proliferation and apoptosis
  156. Hybrid treatment of fibroadipose vascular anomaly: A case report
  157. Surgical treatment for common hepatic aneurysm. Original one-step technique
  158. Neuropsychiatric symptoms, quality of life and caregivers’ burden in dementia
  159. Predictor of postoperative dyspnea for Pierre Robin Sequence infants
  160. Long non-coding RNA FOXD2-AS1 promotes cell proliferation, metastasis and EMT in glioma by sponging miR-506-5p
  161. Analysis of expression and prognosis of KLK7 in ovarian cancer
  162. Circular RNA circ_SETD2 represses breast cancer progression via modulating the miR-155-5p/SCUBE2 axis
  163. Glial cell induced neural differentiation of bone marrow stromal cells
  164. Case Report
  165. Moraxella lacunata infection accompanied by acute glomerulonephritis
  166. Research Article
  167. Diagnosis of complication in lung transplantation by TBLB + ROSE + mNGS
  168. Case Report
  169. Endometrial cancer in a renal transplant recipient: A case report
  170. Research Article
  171. Downregulation of lncRNA FGF12-AS2 suppresses the tumorigenesis of NSCLC via sponging miR-188-3p
  172. Case Report
  173. Splenic abscess caused by Streptococcus anginosus bacteremia secondary to urinary tract infection: a case report and literature review
  174. Research Article
  175. Advances in the role of miRNAs in the occurrence and development of osteosarcoma
  176. Rheumatoid arthritis increases the risk of pleural empyema
  177. Effect of miRNA-200b on the proliferation and apoptosis of cervical cancer cells by targeting RhoA
  178. LncRNA NEAT1 promotes gastric cancer progression via miR-1294/AKT1 axis
  179. Key pathways in prostate cancer with SPOP mutation identified by bioinformatic analysis
  180. Comparison of low-molecular-weight heparins in thromboprophylaxis of major orthopaedic surgery – randomized, prospective pilot study
  181. Case Report
  182. A case of SLE with COVID-19 and multiple infections
  183. Research Article
  184. Circular RNA hsa_circ_0007121 regulates proliferation, migration, invasion, and epithelial–mesenchymal transition of trophoblast cells by miR-182-5p/PGF axis in preeclampsia
  185. SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis
  186. Case Report
  187. A case report of cervical pregnancy after in vitro fertilization complicated by tuberculosis and a literature review
  188. Review Article
  189. Serrated lesions of the colon and rectum: Emergent epidemiological data and molecular pathways
  190. Research Article
  191. Biological properties and therapeutic effects of plant-derived nanovesicles
  192. Case Report
  193. Clinical characterization of chromosome 5q21.1–21.3 microduplication: A case report
  194. Research Article
  195. Serum calcium levels correlates with coronary artery disease outcomes
  196. Rapunzel syndrome with cholangitis and pancreatitis – A rare case report
  197. Review Article
  198. A review of current progress in triple-negative breast cancer therapy
  199. Case Report
  200. Peritoneal-cutaneous fistula successfully treated at home: A case report and literature review
  201. Research Article
  202. Trim24 prompts tumor progression via inducing EMT in renal cell carcinoma
  203. Degradation of connexin 50 protein causes waterclefts in human lens
  204. GABRD promotes progression and predicts poor prognosis in colorectal cancer
  205. The lncRNA UBE2R2-AS1 suppresses cervical cancer cell growth in vitro
  206. LncRNA FOXD3-AS1/miR-135a-5p function in nasopharyngeal carcinoma cells
  207. MicroRNA-182-5p relieves murine allergic rhinitis via TLR4/NF-κB pathway
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2020-0125/html
Scroll to top button